This translational study was designed to explore the association of the quantity and quality of epicardial adipose tissue (EAT) with coronary artery disease (CAD), left atrial remodeling and postoperative atrial fibrillation in a high cardiovascular disease-risk population. The investigators expect to identify new biochemical factors and biomarkers in the crosstalk between the epicardial adipocytes, coronary plaques and atrial cardiomyocytes that are involved in the pathogenesis of atherosclerosis and atrial fibrillation, respectively.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
New onset atrial fibrillation
Timeframe: Intra-hospital (i.e. from surgery until hospital discharge which means 7 days on average)
Left atrial remodelling by transthoracic echocardiography and magnetic resonance imaging
Timeframe: 6-month following aortic valve replacement
Frailty syndrome according to Fried et al. scale
Timeframe: 6-month following aortic valve replacement
Coronary artery disease according to the presence of coronary stenosis and/or calcification
Timeframe: Baseline
Jennifer Mancio, MD, PhD candidate